Facile Synthesis of New Hybrid 2-Quinlolinone Derivatives Structures as Anticancer Drugs for Breast Cancer Treatment
- 3 Downloads
A new series of hybrid 2-quinolinone derivatives were synthesized and confirmed using IR, 1H NMR, 13C NMR, and elemental analyses. The cytotoxic activities of some synthesized hybrid 2-quinolinone derivatives were evaluated on human breast carcinoma cells (MCF-7) using the MTT assay. Cell cycle specificity analysis of the 7-hydroxy-4-methyl-3-bromo-2-oxo-1-(p-chlorobenzoyl) methylquinoline compound revealed cell cycle arrest at the S phase. In addition, this compound showed potent topoisomerase (topo) II inhibitory activity in nano-molar concentration compared to doxorubicin as a reference compound. Also, this compound showed moderate β-tubulin polymerization inhibition activity compared to known tubulin polymerization inhibitor combretastatin A-4.
Keywords:quinolinone cytotoxicity cell cycle analysis topoisomerase II tubulin combretastatin A-4
COMPLIANCE WITH ETHICAL STANDARDS
The work has no studies involving humans or animals as subjects of the study.
Conflict of Interests
Authors declare that they have no conflicts of interests.
- 4.Brian, H., Gunjan, G., Keshar, P., Duy, H.H., and Thu, A.N., Anticancer Res., 2010, vol. 30, pp. 3927–3932.Google Scholar
- 6.Vinod, K.P., Mirdula, U., Mrinalini, U., Vishau, D.G., and Meenal, T., Acta Pharm., 2005, vol. 55, pp. 47–56.Google Scholar
- 12.Alka, P.P. and Sanjay, K.V., Inter.J. Theor. Appl. Sci., 2018, vol. 10, pp. 40–43.Google Scholar